Erasca | Investor Presentation Deck | 41 slides · page 28 of 41
The diagram shows the RAS/MAPK/PI3K signaling pathway. ERAS-801 is shown as an EGFR inhibitor.
Pitch deck · market_sizing · size_opportunity · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 diagram 1/1 table 1/1 title 1/1
Components 4
primary value-chain data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1